Brief: Zevra Therapeutics Sells Sdx Portfolio To Commave Therapeutics For $50 Million
16/03/2026 11:38
March 16 (Reuters) - Zevra Therapeutics Inc ZVRA.O: ZEVRA THERAPEUTICS SELLS SDX PORTFOLIO TO COMMAVE THERAPEUTICS FOR $50 MILLION Source text: ID:nGNX1jxzwS Further company coverage: ZVRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zevra Therapeutics
See all newsZevra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Zevra Therapeutics Q2 revenue rises 53% on MIPLYFFA sales
Zevra Therapeutics Inc expected to post earnings of 11 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor